{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:23:29Z","timestamp":1787217809308,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA051295"],"award-info":[{"award-number":["R01DA051295"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH128869"],"award-info":[{"award-number":["R01MH128869"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-026-10309-7","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:24:53Z","timestamp":1787214293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-Dose Cannabidiol Treatment does not Alter Cognitive Performance in the HIV-1 Transgenic Rat Model of NeuroHIV"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1846-3232","authenticated-orcid":false,"given":"Samantha M.","family":"Ayoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunitha","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpi","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-5776","authenticated-orcid":false,"given":"Jared W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"5","key":"10309_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/QAI.0000000000002484","volume":"85","author":"AM Anderson","year":"2020","unstructured":"Anderson AM, Jang JH, Easley KA, Fuchs D, Gisslen M, Zetterberg H, Blennow K, Ellis RJ, Franklin D, Heaton RK, Grant I, Letendre SL (2020) Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection. J Acquir Immune Defic Syndr 85(5):617\u2013625. https:\/\/doi.org\/10.1097\/QAI.0000000000002484","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10309_CR3","doi-asserted-by":"publisher","unstructured":"Ayoub SM, Noback MN, Ahern J, Young JW (2024b) Using cross-species behavioral tools to determine mechanisms contributing to HIV-associated neurocognitive disorder and comorbid substance use. In: Hu G, Xiong H, Buch S (eds) HIV-Associated Neurocognitive Disorders. Elsevier. https:\/\/doi.org\/10.1016\/B978-0-323-99744-7.00032-8","DOI":"10.1016\/B978-0-323-99744-7.00032-8"},{"issue":"3","key":"10309_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11904-024-00698-w","volume":"21","author":"SM Ayoub","year":"2024","unstructured":"Ayoub SM, Holloway BM, Miranda AH, Roberts BZ, Young JW, Minassian A, Ellis RJ (2024a) The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies. Curr HIV\/AIDS Rep 21(3):87\u2013115. https:\/\/doi.org\/10.1007\/s11904-024-00698-w","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10309_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbi.2025.04.030","volume":"128","author":"SM Ayoub","year":"2025","unstructured":"Ayoub SM, Vemuri S, Hoang EB, Jha NA, Minassian A, Young JW (2025) Beneficial and adverse effects of THC on cognition in the HIV-1 transgenic rat model: Importance of exploring task- and sex-dependent outcomes. Brain Behav Immun 128:571\u2013588. https:\/\/doi.org\/10.1016\/j.bbi.2025.04.030","journal-title":"Brain Behav Immun"},{"key":"10309_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugalcdep.2016.11.030","volume":"172","author":"S Babalonis","year":"2017","unstructured":"Babalonis S, Haney M, Malcolm RJ, Lofwall MR, Votaw VR, Sparenborg S, Walsh SL (2017) Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug Alcohol Depend 172:9\u201313. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.030","journal-title":"Drug Alcohol Depend"},{"key":"10309_CR6","doi-asserted-by":"publisher","first-page":"107280","DOI":"10.1016\/j.eplepsyres.2023.107280","volume":"200","author":"AT Berg","year":"2024","unstructured":"Berg AT, Dixon-Salazar T, Meskis MA, Danese SR, Le NMD, Perry MS (2024) Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey. Epilepsy Res 200:107280. https:\/\/doi.org\/10.1016\/j.eplepsyres.2023.107280","journal-title":"Epilepsy Res"},{"issue":"7","key":"10309_CR7","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","volume":"235","author":"DL Boggs","year":"2018","unstructured":"Boggs DL, Surti T, Gupta A, Gupta S, Niciu M, Pittman B, Martin S, Thurnauer AM, Davies H, D\u2019Souza A, D. C., Ranganathan M (2018) The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial. Psychopharmacology 235(7):1923\u20131932. https:\/\/doi.org\/10.1007\/s00213-018-4885-9","journal-title":"Psychopharmacology"},{"key":"10309_CR8","doi-asserted-by":"publisher","first-page":"110526","DOI":"10.1016\/j.neuropharm.2025.110526","volume":"277","author":"S Borras-Pernas","year":"2025","unstructured":"Borras-Pernas S, Sancho-Balsells A, Patterer L, Wang M, Del Toro D, Alberch J, Schibano D, Espel J, Heybeck M, Scheidel B, Giralt A (2025) Low-dose cannabidiol treatment prevents chronic stress-induced phenotypes and is associated with multiple synaptic changes across various brain regions. Neuropharmacology 277:110526. https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110526","journal-title":"Neuropharmacology"},{"key":"10309_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","volume":"112","author":"AC Campos","year":"2016","unstructured":"Campos AC, Fogaca MV, Sonego AB, Guimaraes FS (2016) Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol Res 112:119\u2013127. https:\/\/doi.org\/10.1016\/j.phrs.2016.01.033","journal-title":"Pharmacol Res"},{"key":"10309_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2010.06.023","volume":"1348","author":"OJ Cassol Jr","year":"2010","unstructured":"Cassol OJ Jr., Comim CM, Silva BR, Hermani FV, Constantino LS, Felisberto F, Petronilho F, Hallak JE, De Martinis BS, Zuardi AW, Crippa JA, Quevedo J, Dal-Pizzol F (2010) Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture. Brain Res 1348:128\u2013138. https:\/\/doi.org\/10.1016\/j.brainres.2010.06.023","journal-title":"Brain Res"},{"key":"10309_CR11","doi-asserted-by":"publisher","unstructured":"Castillo-Arellano J, Canseco-Alba A, Cutler SJ, Leon F (2023) The polypharmacological effects of cannabidiol. Molecules 28(7). https:\/\/doi.org\/10.3390\/molecules28073271","DOI":"10.3390\/molecules28073271"},{"issue":"2","key":"10309_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40429-017-0142-2","volume":"4","author":"M Colizzi","year":"2017","unstructured":"Colizzi M, Bhattacharyya S (2017) Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition. Curr Addict Rep 4(2):62\u201374. https:\/\/doi.org\/10.1007\/s40429-017-0142-2","journal-title":"Curr Addict Rep"},{"issue":"1","key":"10309_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","volume":"160","author":"D De Gregorio","year":"2019","unstructured":"De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, Aboud M, Maione S, Comai S, Gobbi G (2019) Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain 160(1):136\u2013150. https:\/\/doi.org\/10.1097\/j.pain.0000000000001386","journal-title":"Pain"},{"key":"10309_CR14","doi-asserted-by":"publisher","first-page":"1033712","DOI":"10.3389\/fimmu.2022.1033712","volume":"13","author":"EGM de Menezes","year":"2022","unstructured":"de Menezes EGM, Liu JS, Bowler SA, Giron LB, D\u2019Antoni ML, Shikuma CM, Abdel-Mohsen M, Ndhlovu LC, Norris PJ (2022) Circulating brain-derived extracellular vesicles expressing neuroinflammatory markers are associated with HIV-related neurocognitive impairment. Front Immunol 13:1033712. https:\/\/doi.org\/10.3389\/fimmu.2022.1033712","journal-title":"Front Immunol"},{"key":"10309_CR15","doi-asserted-by":"publisher","unstructured":"DeMarino C, Cowen M, Khatkar P, Cotto B, Branscome H, Kim Y, Sharif SA, Agbottah ET, Zhou W, Costiniuk CT, Jenabian MA, Gelber C, Liotta LA, Langford D, Kashanchi F (2022) Cannabinoids reduce extracellular vesicle release from HIV-1 infected myeloid cells and inhibit viral transcription. Cells 11(4). https:\/\/doi.org\/10.3390\/cells11040723","DOI":"10.3390\/cells11040723"},{"issue":"1","key":"10309_CR16","doi-asserted-by":"publisher","first-page":"e16243","DOI":"10.1111\/jnc.16243","volume":"169","author":"TD Dexter","year":"2025","unstructured":"Dexter TD, Roberts BZ, Ayoub SM, Noback M, Barnes SA, Young JW (2025) Cross-species translational paradigms for assessing positive valence system as defined by the RDoC matrix. J Neurochem 169(1):e16243. https:\/\/doi.org\/10.1111\/jnc.16243","journal-title":"J Neurochem"},{"issue":"7","key":"10309_CR17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/QAD.0000000000004143","volume":"39","author":"MM Diaz","year":"2025","unstructured":"Diaz MM, Kamalyan L, Al-Rousan T, Breton J, Franklin DR Jr., Umlauf A, Ellis RJ, Cherner M, Iudicello J, Heaton RK, Letendre SL, Marquine MJ (2025) Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among US Latinos with HIV. AIDS 39(7):838\u2013847. https:\/\/doi.org\/10.1097\/QAD.0000000000004143","journal-title":"AIDS"},{"issue":"11","key":"10309_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41582-023-00879-y","volume":"19","author":"RJ Ellis","year":"2023","unstructured":"Ellis RJ, Marquine MJ, Kaul M, Fields JA, Schlachetzki JCM (2023) Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management. Nat Rev Neurol 19(11):668\u2013687. https:\/\/doi.org\/10.1038\/s41582-023-00879-y","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10309_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/0269881112460109","volume":"27","author":"A Englund","year":"2013","unstructured":"Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, Stone JM, Reichenberg A, Brenneisen R, Holt D, Feilding A, Walker L, Murray RM, Kapur S (2013) Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J Psychopharmacol 27(1):19\u201327. https:\/\/doi.org\/10.1177\/0269881112460109","journal-title":"J Psychopharmacol"},{"key":"10309_CR20","doi-asserted-by":"publisher","first-page":"109316","DOI":"10.1016\/j.neuropharm.2022.109316","volume":"223","author":"JM Franzen","year":"2023","unstructured":"Franzen JM, Werle I, Vanz F, de Oliveira BB, Nascimento M, Guimaraes LM, F. S., Bertoglio LJ (2023) Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT(1A) but not CB1 or CB2 receptors. Neuropharmacology 223:109316. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109316","journal-title":"Neuropharmacology"},{"issue":"4","key":"10309_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/108729104323038892","volume":"18","author":"MD Furler","year":"2004","unstructured":"Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R (2004) Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDS 18(4):215\u2013228. https:\/\/doi.org\/10.1089\/108729104323038892","journal-title":"AIDS Patient Care STDS"},{"issue":"7","key":"10309_CR22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1037\/neu0000366","volume":"31","author":"D Gomez","year":"2017","unstructured":"Gomez D, Power C, Gill MJ, Fujiwara E (2017) Determinants of risk-taking in HIV-associated neurocognitive disorders. Neuropsychology 31(7):798\u2013810. https:\/\/doi.org\/10.1037\/neu0000366","journal-title":"Neuropsychology"},{"issue":"1","key":"10309_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1590\/s1516-44462010000100011","volume":"32","author":"JE Hallak","year":"2010","unstructured":"Hallak JE, Machado-de-Sousa JP, Crippa JA, Sanches RF, Trzesniak C, Chaves C, Bernardo SA, Regalo SC, Zuardi AW (2010) Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD). Braz J Psychiatry 32(1):56\u201361. https:\/\/doi.org\/10.1590\/s1516-44462010000100011","journal-title":"Braz J Psychiatry"},{"issue":"3","key":"10309_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1037\/0894-4105.20.3.355","volume":"20","author":"DJ Hardy","year":"2006","unstructured":"Hardy DJ, Hinkin CH, Levine AJ, Castellon SA, Lam MN (2006) Risky decision making assessed with the gambling task in adults with HIV. Neuropsychology 20(3):355\u2013360. https:\/\/doi.org\/10.1037\/0894-4105.20.3.355","journal-title":"Neuropsychology"},{"issue":"4","key":"10309_CR63","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.1021\/acs.jmedchem.5c02796","volume":"69","author":"DH Haymer","year":"2026","unstructured":"Haymer DH, Duncan RA, Rodriguez AL, Han A, Lindsay RJ, Wijesiri NK, Gray T, Krishnan A, Qi S, Brown A, Boutaud BP, Engers O, Jones DW, Niswender CK, Lindsley CM, C. W., Bender AM (2026) Drug Repurposing: Conversion of the Peripherally Restricted HIV Protease Inhibitor Amprenavir to Potent, Selective, and CNS-Penetrant Agonists for the Cannabinoid Receptor 2. J Med Chem 69(4):4187\u20134207. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02796","journal-title":"J Med Chem"},{"key":"10309_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jad.2016.02.003","volume":"196","author":"R Hershenberg","year":"2016","unstructured":"Hershenberg R, Satterthwaite TD, Daldal A, Katchmar N, Moore TM, Kable JW, Wolf DH (2016) Diminished effort on a progressive ratio task in both unipolar and bipolar depression. J Affect Disord 196:97\u2013100. https:\/\/doi.org\/10.1016\/j.jad.2016.02.003","journal-title":"J Affect Disord"},{"issue":"3","key":"10309_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.euroneuro.2014.11.014","volume":"25","author":"C Hindocha","year":"2015","unstructured":"Hindocha C, Freeman TP, Schafer G, Gardener C, Das RK, Morgan CJ, Curran HV (2015) Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users. Eur Neuropsychopharmacol 25(3):325\u2013334. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.11.014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10309_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jpsychires.2021.09.007","volume":"143","author":"J Hotz","year":"2021","unstructured":"Hotz J, Fehlmann B, Papassotiropoulos A, de Quervain DJ, Schicktanz NS (2021) Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial. J Psychiatr Res 143:327\u2013333. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.09.007","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10309_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/infdis\/jiw506","volume":"215","author":"BM Imp","year":"2017","unstructured":"Imp BM, Rubin LH, Tien PC, Plankey MW, Golub ET, French AL, Valcour VG (2017) Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression. J Infect Dis 215(1):114\u2013121. https:\/\/doi.org\/10.1093\/infdis\/jiw506","journal-title":"J Infect Dis"},{"issue":"7","key":"10309_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/13803390701779578","volume":"30","author":"JE Iudicello","year":"2008","unstructured":"Iudicello JE, Woods SP, Weber E, Dawson MS, Scott JC, Carey CL, Grant I, Group, H. I. V. N. R. C. (2008) Cognitive mechanisms of switching in HIV-associated category fluency deficits. J Clin Exp Neuropsychol 30(7):797\u2013804. https:\/\/doi.org\/10.1080\/13803390701779578","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2","key":"10309_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/13854046.2012.740077","volume":"27","author":"JE Iudicello","year":"2013","unstructured":"Iudicello JE, Woods SP, Cattie JE, Doyle K, Grant I, Group, H. I. V. N. R. P. (2013) Risky decision-making in HIV-associated neurocognitive disorders (HAND). Clin Neuropsychol 27(2):256\u2013275. https:\/\/doi.org\/10.1080\/13854046.2012.740077","journal-title":"Clin Neuropsychol"},{"issue":"8","key":"10309_CR31","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s00213-025-06761-7","volume":"242","author":"NA Jha","year":"2025","unstructured":"Jha NA, Ayoub SM, Flesher MM, Morton K, Sikkink M, Guglielmo G, Khokhar JY, Minassian A, Brody AL, Young JW (2025) Acute nicotine vapor attenuates sensorimotor gating deficits in HIV-1 transgenic rats. Psychopharmacology 242(8):1783\u20131796. https:\/\/doi.org\/10.1007\/s00213-025-06761-7","journal-title":"Psychopharmacology"},{"issue":"3","key":"10309_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1600-0404.1992.tb05078.x","volume":"86","author":"NR Karlsen","year":"1992","unstructured":"Karlsen NR, Reinvang I, Froland SS (1992) Slowed reaction time in asymptomatic HIV-positive patients. Acta Neurol Scand 86(3):242\u2013246. https:\/\/doi.org\/10.1111\/j.1600-0404.1992.tb05078.x","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"10309_CR33","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/npp.2015.39","volume":"40","author":"JP Kesby","year":"2015","unstructured":"Kesby JP, Heaton RK, Young JW, Umlauf A, Woods SP, Letendre SL, Markou A, Grant I, Semenova S (2015) Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice. Neuropsychopharmacology 40(8):1899\u20131909. https:\/\/doi.org\/10.1038\/npp.2015.39","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10309_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/09540121.2018.1499858","volume":"31","author":"K Langan","year":"2019","unstructured":"Langan K, Wall M, Potts W, Himelhoch S (2019) Prevalence and potential predictors of gambling disorder among people living with HIV. AIDS Care 31(4):421\u2013426. https:\/\/doi.org\/10.1080\/09540121.2018.1499858","journal-title":"AIDS Care"},{"issue":"2","key":"10309_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00213-022-06303-5","volume":"240","author":"R Lees","year":"2023","unstructured":"Lees R, Hines LA, Hindocha C, Baio G, Shaban NDC, Stothart G, Mofeez A, Morgan CJA, Curran HV, Freeman TP (2023) Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder. Psychopharmacology 240(2):337\u2013346. https:\/\/doi.org\/10.1007\/s00213-022-06303-5","journal-title":"Psychopharmacology"},{"key":"10309_CR36","doi-asserted-by":"publisher","first-page":"614811","DOI":"10.3389\/fphar.2021.614811","volume":"12","author":"FM Leweke","year":"2021","unstructured":"Leweke FM, Rohleder C, Gerth CW, Hellmich M, Pukrop R, Koethe D (2021) Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial. Front Pharmacol 12:614811. https:\/\/doi.org\/10.3389\/fphar.2021.614811","journal-title":"Front Pharmacol"},{"issue":"4","key":"10309_CR37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/sj.npp.1300838","volume":"31","author":"LE Long","year":"2006","unstructured":"Long LE, Malone DT, Taylor DA (2006) Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice. Neuropsychopharmacology 31(4):795\u2013803. https:\/\/doi.org\/10.1038\/sj.npp.1300838","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10309_CR38","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1089\/can.2023.0139","volume":"9","author":"S Marini","year":"2024","unstructured":"Marini S, Huber A, Cash MN, Salemi M, Cook RL, Borsa P, Mavian CN (2024) Oral Cannabidiol Treatment Is Associated with an Anti-Inflammatory Gene Expression Signature in Myeloid Cells of People Living with HIV. Cannabis Cannabinoid Res 9(4):1028\u20131037. https:\/\/doi.org\/10.1089\/can.2023.0139","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"10309_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41398-025-03718-4","volume":"15","author":"A Miranda","year":"2025","unstructured":"Miranda A, Roberts BZ, Holloway BM, Peek E, Rosberg H, Ayoub SM, Piomelli D, Jung KM, Barnes SA, Rossi S, Geyer MA, Perry W, Minassian A, Young JW (2025) Chronic cannabis use in people with bipolar disorder is associated with comparable decision-making and functional outcome to healthy participants. Transl Psychiatry 15(1):506. https:\/\/doi.org\/10.1038\/s41398-025-03718-4","journal-title":"Transl Psychiatry"},{"key":"10309_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fnbeh.2019.00169","volume":"13","author":"LM Moran","year":"2019","unstructured":"Moran LM, McLaurin KA, Booze RM, Mactutus CF (2019) Neurorestoration of Sustained Attention in a Model of HIV-1 Associated Neurocognitive Disorders. Front Behav Neurosci 13:169. https:\/\/doi.org\/10.3389\/fnbeh.2019.00169","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"10309_CR41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jiac.2019.09.008","volume":"26","author":"A Nakao","year":"2020","unstructured":"Nakao A, Yamanouchi J, Takenaka K, Takada K (2020) The Iowa Gambling Task on HIV-infected subjects. J Infect Chemother 26(3):240\u2013244. https:\/\/doi.org\/10.1016\/j.jiac.2019.09.008","journal-title":"J Infect Chemother"},{"issue":"2","key":"10309_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3758\/s13415-023-01150-z","volume":"24","author":"M Noback","year":"2024","unstructured":"Noback M, Bhakta SG, Talledo JA, Kotz JE, Benster L, Roberts BZ, Nungaray JA, Light GA, Swerdlow NR, Brigman JL, Cavanagh JF, Young JW (2024) Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker. Cogn Affect Behav Neurosci 24(2):269\u2013278. https:\/\/doi.org\/10.3758\/s13415-023-01150-z","journal-title":"Cogn Affect Behav Neurosci"},{"issue":"2","key":"10309_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/epi.14629","volume":"60","author":"PH Patra","year":"2019","unstructured":"Patra PH, Barker-Haliski M, White HS, Whalley BJ, Glyn S, Sandhu H, Jones N, Bazelot M, Williams CM, McNeish AJ (2019) Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models. Epilepsia 60(2):303\u2013314. https:\/\/doi.org\/10.1111\/epi.14629","journal-title":"Epilepsia"},{"issue":"12","key":"10309_CR44","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1111\/bph.15003","volume":"177","author":"PH Patra","year":"2020","unstructured":"Patra PH, Serafeimidou-Pouliou E, Bazelot M, Whalley BJ, Williams CM, McNeish AJ (2020) Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice. Br J Pharmacol 177(12):2779\u20132792. https:\/\/doi.org\/10.1111\/bph.15003","journal-title":"Br J Pharmacol"},{"key":"10309_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3389\/fphar.2018.00901","volume":"9","author":"FF Peres","year":"2018","unstructured":"Peres FF, Diana MC, Levin R, Suiama MA, Almeida V, Vendramini AM, Santos CM, Zuardi AW, Hallak JEC, Crippa JA, Abilio VC (2018) Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia. Front Pharmacol 9:901. https:\/\/doi.org\/10.3389\/fphar.2018.00901","journal-title":"Front Pharmacol"},{"issue":"4","key":"10309_CR46","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/schbul\/sbv226","volume":"42","author":"LF Reddy","year":"2016","unstructured":"Reddy LF, Waltz JA, Green MF, Wynn JK, Horan WP (2016) Probabilistic Reversal Learning in Schizophrenia: Stability of Deficits and Potential Causal Mechanisms. Schizophr Bull 42(4):942\u2013951. https:\/\/doi.org\/10.1093\/schbul\/sbv226","journal-title":"Schizophr Bull"},{"issue":"16","key":"10309_CR47","doi-asserted-by":"publisher","first-page":"9271","DOI":"10.1073\/pnas.161290298","volume":"98","author":"W Reid","year":"2001","unstructured":"Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr., Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O\u2019Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98(16):9271\u20139276. https:\/\/doi.org\/10.1073\/pnas.161290298","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10309_CR49","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/ijnp\/pyab053","volume":"24","author":"BZ Roberts","year":"2021","unstructured":"Roberts BZ, Minassian A, Halberstadt AL, He YV, Chatha M, Geyer MA, Grant I, Young JW (2021b) HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Delta9-Tetrahydrocannabinol)-Induced Deficits. Int J Neuropsychopharmacol 24(11):894\u2013906. https:\/\/doi.org\/10.1093\/ijnp\/pyab053","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"10309_CR48","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3758\/s13415-021-00926-5","volume":"21","author":"BZ Roberts","year":"2021","unstructured":"Roberts BZ, He YV, Chatha M, Minassian A, Grant I, Young JW (2021a) HIV Transgenic Rats Demonstrate Superior Task Acquisition and Intact Reversal Learning in the Within-Session Probabilistic Reversal Learning Task. Cogn Affect Behav Neurosci 21(6):1207\u20131221. https:\/\/doi.org\/10.3758\/s13415-021-00926-5","journal-title":"Cogn Affect Behav Neurosci"},{"issue":"5","key":"10309_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","volume":"18","author":"K Robertson","year":"2012","unstructured":"Robertson K, Liner J, Meeker RB (2012) Antiretroviral neurotoxicity. J Neurovirol 18(5):388\u2013399. https:\/\/doi.org\/10.1007\/s13365-012-0120-3","journal-title":"J Neurovirol"},{"issue":"1\u20132","key":"10309_CR64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2012.03.015","volume":"247","author":"W Royal","year":"2012","unstructured":"Royal W 3rd, Zhang L, Guo M, Jones O, Davis H, Bryant JL (2012) Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J Neuroimmunol 247(1\u20132):16\u201324. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.015","journal-title":"J Neuroimmunol"},{"issue":"5","key":"10309_CR51","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/QAD.0b013e3283437f9a","volume":"25","author":"J Schouten","year":"2011","unstructured":"Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P (2011) HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 25(5):561\u2013575. https:\/\/doi.org\/10.1097\/QAD.0b013e3283437f9a","journal-title":"AIDS"},{"issue":"1\u20133","key":"10309_CR52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.schres.2011.04.017","volume":"130","author":"CD Schubart","year":"2011","unstructured":"Schubart CD, Sommer IE, van Gastel WA, Goetgebuer RL, Kahn RS, Boks MP (2011) Cannabis with high cannabidiol content is associated with fewer psychotic experiences. Schizophr Res 130(1\u20133):216\u2013221. https:\/\/doi.org\/10.1016\/j.schres.2011.04.017","journal-title":"Schizophr Res"},{"key":"10309_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.addbeh.2017.01.015","volume":"68","author":"S Shiau","year":"2017","unstructured":"Shiau S, Arpadi SM, Yin MT, Martins SS (2017) Patterns of drug use and HIV infection among adults in a nationally representative sample. Addict Behav 68:39\u201344. https:\/\/doi.org\/10.1016\/j.addbeh.2017.01.015","journal-title":"Addict Behav"},{"key":"10309_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jad.2024.01.016","volume":"350","author":"JL Thompson","year":"2024","unstructured":"Thompson JL, Woods SP, Medina LD, Garcia JM, Teixeira AL (2024) Apathy in persons living with HIV disease: A systematic narrative review. J Affect Disord 350:133\u2013147. https:\/\/doi.org\/10.1016\/j.jad.2024.01.016","journal-title":"J Affect Disord"},{"issue":"3","key":"10309_CR62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/QAD.0000000000000538","volume":"29","author":"J Underwood","year":"2015","unstructured":"Underwood J, Robertson KR, Winston A (2015) Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitiveimpairment in treated HIV disease? AIDS 29(3):253\u2013261. https:\/\/doi.org\/10.1097\/QAD.0000000000000538","journal-title":"AIDS"},{"key":"10309_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-025-00383-8","author":"S Vemuri","year":"2026","unstructured":"Vemuri S, Ayoub SM, Minassian A, Young JW (2026) THC induced similar physiological effects on HIV transgenic rats and their controls without affecting HIV-induced deficits in effortful motivation. J Cannabis Res. https:\/\/doi.org\/10.1186\/s42238-025-00383-8","journal-title":"J Cannabis Res"},{"issue":"4","key":"10309_CR56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","volume":"10","author":"DT Wade","year":"2004","unstructured":"Wade DT, Makela P, Robson P, House H, Bateman C (2004) Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 10(4):434\u2013441. https:\/\/doi.org\/10.1191\/1352458504ms1082oa","journal-title":"Mult Scler"},{"key":"10309_CR57","doi-asserted-by":"publisher","first-page":"581346","DOI":"10.3389\/fneur.2020.581346","volume":"11","author":"J Wei","year":"2020","unstructured":"Wei J, Hou J, Su B, Jiang T, Guo C, Wang W, Zhang Y, Chang B, Wu H, Zhang T (2020) The Prevalence of Frascati-Criteria-Based HIV-Associated Neurocognitive Disorder (HAND) in HIV-Infected Adults: A Systematic Review and Meta-Analysis. Front Neurol 11:581346. https:\/\/doi.org\/10.3389\/fneur.2020.581346","journal-title":"Front Neurol"},{"issue":"1","key":"10309_CR58","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1038\/s41598-023-32927-4","volume":"13","author":"A Yndart Arias","year":"2023","unstructured":"Yndart Arias A, Kolishetti N, Vashist A, Madepalli L, Llaguno L, Nair M (2023) Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1. Sci Rep 13(1):7376. https:\/\/doi.org\/10.1038\/s41598-023-32927-4","journal-title":"Sci Rep"},{"issue":"2","key":"10309_CR59","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s13365-013-0150-5","volume":"19","author":"L Yuan","year":"2013","unstructured":"Yuan L, Qiao L, Wei F, Yin J, Liu L, Ji Y, Smith D, Li N, Chen D (2013) Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. J Neurovirol 19(2):144\u2013149. https:\/\/doi.org\/10.1007\/s13365-013-0150-5","journal-title":"J Neurovirol"},{"issue":"4","key":"10309_CR60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1590\/s0100-879x2006000400001","volume":"39","author":"AW Zuardi","year":"2006","unstructured":"Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimaraes FS (2006) Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res 39(4):421\u2013429. https:\/\/doi.org\/10.1590\/s0100-879x2006000400001","journal-title":"Braz J Med Biol Res"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10309-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-026-10309-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10309-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:24:54Z","timestamp":1787214294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-026-10309-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10309"],"URL":"https:\/\/doi.org\/10.1007\/s11481-026-10309-7","relation":{},"ISSN":["1557-1904"],"issn-type":[{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"42"}}